Results 201 to 210 of about 686,098 (387)

SAFETY AND EFFICACY OF A LOW DOSE CORTICOSTEROID REGIMEN FOR THE INDUCTION TREATMENT OF LUPUS NEPHRITIS - CYCLONES TRIAL: CYCLOPHOSPHAMIDE LOW DOSE AND NO EXTRA STEROID

, 2021
Michelle Lopes, Sandra Gofinet Pasoto, Emily Figueiredo Neves Yuki, Lorena Elizabeth Betancourt Villamarín, Francisco Fellipe Claudino Formiga, Débora Cordeiro do Rosário, L.M.K.R. Brandão, Carolina Torres Ribeiro, Tatiana do Nascimento Pedrosa, Alex Cardoso Lopes, Eduardo Ferreira Borba, Luciana Parente Costa Seguro, Nádia Emi Aikawa, Eloísa Bonfá   +13 more
openalex   +1 more source

Infection Risk and Safety of Corticosteroid Use.

Rheumatic Disease Clinics of North America, 2016
J. Youssef, S. Novosad, K. Winthrop
semanticscholar   +1 more source

Corticosteroid use before ICU admission and 90-day all-cause readmission risk in patients with acute exacerbation of chronic obstructive pulmonary disease: an analysis of the MIMIC-IV database. [PDF]

J Thorac Dis
Jiang C, Huang J, Chen B, Yang S.
europepmc   +1 more source

Dyspnea and Inhaled Corticosteroid and Long-acting β-Agonist Therapy in an Occupational Cohort: A Longitudinal Study

, 2020
Barbara Putman, Lies Lahousse, Ankura Singh, Rachel Zeig‐Owens, Charles B. Hall, Melissa Fazzari, Theresa Schwartz, Mayris P. Webber, Hillel W. Cohen, David J. Prezant, Michael D. Weiden   +10 more
openalex   +2 more sources

P1603Efficacy of combination therapy of methotrexate and low-dose corticosteroid for cardiac sarcoidosis evaluated by fuluorine-18 fluorodeoxyglucose positron emission tomography [PDF]

, 2018
Takafumi Yokomatsu, S. Hojo, Tetsuma Kawaji, Akihiro Kushiyama, Kenji Nakatsuma, Kazuhisa Kaneda, Masashi Kato, S Miki   +7 more
openalex   +1 more source

Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: the Randomized, Phase 3, TULIP‐SC Study

Arthritis &Rheumatology, Accepted Article.
Objective The multinational, phase 3, double‐blind, placebo‐controlled TULIP‐SC trial evaluated the efficacy and safety of subcutaneous anifrolumab in adults who have moderate‐to‐severe SLE activity, despite receiving standard therapy. Methods Adults with SLE received subcutaneous anifrolumab 120 mg or placebo once weekly for 52 weeks (1:1 ...
Susan Manzi, Ian N. Bruce, Eric F. Morand, Richard Furie, Yoshiya Tanaka, Kenneth C. Kalunian, Anca Askanase, Patricia Puzio, Emon Khan, Jenny Wissmar, Michael Song, Catharina Lindholm, The TULIP‐SC investigators   +12 more
wiley   +1 more source

Lateral Epicondylitis With Soft Tissue Atrophy Due to Repeated Corticosteroid Injections: Comparison of Open and Arthroscopic Surgery. [PDF]

Orthop J Sports Med
Albayrak K, Jacxsens M, Kurk MB, Onder M, Dedeoglu SS, Spross C.   +5 more
europepmc   +1 more source

Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry

Thorax, 2016
J. Sweeney, C. Patterson, A. Menzies-Gow, R. Niven, A. Mansur, C. Bucknall, R. Chaudhuri, D. Price, C. Brightling, L. Heaney   +9 more
semanticscholar   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists, Sodium‐Glucose Cotransporter‐2 Inhibitors, and Risk of Autoimmune Rheumatic Diseases

Arthritis &Rheumatology, Accepted Article.
Objective GLP‐1 receptor agonists (GLP‐1RAs) and SGLT2 inhibitors (SGLT2is) facilitate weight loss and exhibit immunomodulatory effects, but their impact on the risk of developing autoimmune rheumatic diseases (ARDs) is unclear. We compared ARD incidence following initiation of GLP‐1RAs, or SGLT2is, vs.
Derin Karacabeyli, Diane Lacaille, Na Lu, Hui Xie, J. Antonio Aviña‐Zubieta   +4 more
wiley   +1 more source

Systemic Corticosteroid as an Adjunct for Acute Respiratory Distress Syndrome in Non-Fatal Fresh Water Drowning: An Evidence-based Case Report

Acta Medica Indonesiana
Background: Acute lung injury or acute respiratory distress syndrome (ARDS) is one of the most common complications of non-fatal drowning. Although respiratory societies’ guidelines endorse the role of systemic corticosteroids in ARDS, the evidence for ...
Eric Daniel Tenda, Joshua Henrina, Andry Setiadharma, Ceva Wicaksono Pitoyo, Mira Yulianti, Raden Fidiaji Hiltono Santoso, Kuntjoro Harimurti, Czeresna Heriawan Soejono   +7 more
doaj